Talphera Inc (TLPH)

Jun 06, 2025

Talphera, Inc. (NASDAQ:TLPH) Q1 2025 Earnings Call Transcript - MSN

Jun 06, 2025

Jun 05, 2025

talphera receives extension to meet nasdaq listing requirements - Investing.com India

Jun 05, 2025

Jun 05, 2025

talphera receives extension to meet nasdaq listing requirements By Investing.com - Investing.com South Africa

Jun 05, 2025

Jun 05, 2025

Talphera Granted Extension for Nasdaq Compliance - TipRanks

Jun 05, 2025

May 29, 2025

Financial Review: Talphera (NASDAQ:TLPH) & Alterity Therapeutics (NASDAQ:ATHE) - Defense World

May 29, 2025

May 17, 2025

Talphera’s Strategic Advancements and Financial Stability Reinforce Buy Rating - TipRanks

May 17, 2025

May 15, 2025

Talphera outlines accelerated NEPHRO CRRT study timeline with completion targeted by end of 2025, supported by new site activations and $14.8M financing - MSN

May 15, 2025

May 15, 2025

Talphera, Inc. Earnings Call: Strategic Adjustments and Financial Progress - TipRanks

May 15, 2025

May 15, 2025

TLPH Prepares to Finalize NEPHRO CRRT Registration Trial | TLPH Stock News - GuruFocus

May 15, 2025

May 15, 2025

Talphera: Q1 Earnings Snapshot - Greenwich Time

May 15, 2025

May 15, 2025

Talphera Inc (TLPH) Q1 2025 Earnings Call Highlights: Strategic Cost Reductions and FDA ... - Yahoo Finance

May 15, 2025

May 15, 2025

Talphera, Inc. Reports Q1 2025 Financial Results - TipRanks

May 15, 2025

May 14, 2025

Talphera Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 14, 2025

May 14, 2025

Earnings call transcript: Talphera Inc. outlines strategic shifts in Q1 2025 - Investing.com Nigeria

May 14, 2025

May 14, 2025

TLPH Reports Strong Q1 Revenue with Promising Study Progress | T - GuruFocus

May 14, 2025

May 14, 2025

Talphera Inc Reports Q1 2025 EPS Loss of $0.10, Beating Estimates; Revenue Details Unavailable - GuruFocus

May 14, 2025

May 14, 2025

TALPHERA, INC. SEC 10-Q Report - TradingView

May 14, 2025

May 14, 2025

TLPH Reports Strong Q1 Revenue with Promising Study Progress | TLPH Stock News - GuruFocus

May 14, 2025

May 14, 2025

Talphera Announces First Quarter 2025 Financial Results and Prov - GuruFocus

May 14, 2025

May 14, 2025

Talphera Cuts Net Loss 32%, Secures FDA Approval for Streamlined Clinical Trial Design - Stock Titan

May 14, 2025

May 14, 2025

Talphera Announces First Quarter 2025 Financial Results and Provides Corporate Update | TLPH Stock News - GuruFocus

May 14, 2025

May 14, 2025

Talphera reports Q1 EPS (10c), consensus (14c) - TipRanks

May 14, 2025

May 14, 2025

Talphera Announces First Quarter 2025 Financial Results and Provides Corporate Update - PR Newswire

May 14, 2025

May 08, 2025

Talphera to Host First Quarter Financial Results and Corporate Update Call and Webcast on Wednesday, May 14, 2025 - Citizen Tribune

May 08, 2025

May 07, 2025

Talphera to Host First Quarter Financial Results and Corporate Update Call and Webcast on Wednesday, May 14, 2025 | TLPH Stock News - GuruFocus

May 07, 2025

May 06, 2025

All You Need to Know About Talphera (TLPH) Rating Upgrade to Strong Buy - Yahoo Finance

May 06, 2025

Apr 05, 2025

HC Wainwright Predicts Talphera’s Q1 Earnings (NASDAQ:TLPH) - Defense World

Apr 05, 2025

Apr 04, 2025

Talphera (TLPH) Upgraded to Buy: What Does It Mean for the Stock? - MSN

Apr 04, 2025

Apr 04, 2025

HC Wainwright Estimates Talphera FY2029 Earnings - Defense World

Apr 04, 2025

Apr 03, 2025

Talphera CEO Makes Bold Move with Major Stock Purchase! - TipRanks

Apr 03, 2025

Apr 03, 2025

Talphera CEO Vincent Angotti buys $124,999 in common stock By Investing.com - Investing.com Canada

Apr 03, 2025

Apr 03, 2025

Talphera CEO Vincent Angotti buys $124,999 in common stock - Investing.com

Apr 03, 2025

Apr 02, 2025

Talphera (NASDAQ:TLPH) Given Buy Rating at HC Wainwright - Defense World

Apr 02, 2025

Apr 01, 2025

Talphera, Inc. Earnings Call: Progress Amid Challenges - TipRanks

Apr 01, 2025

Apr 01, 2025

H.C. Wainwright maintains Buy on Talphera stock, $6 target By Investing.com - Investing.com Canada

Apr 01, 2025

Apr 01, 2025

Strategic Advancements and FDA Agreement Propel Talphera’s Positive Outlook with Buy Rating - TipRanks

Apr 01, 2025

Apr 01, 2025

H.C. Wainwright maintains Buy on Talphera stock, $6 target - Investing.com India

Apr 01, 2025

Apr 01, 2025

Talphera: Q4 Earnings Snapshot - CT Insider

Apr 01, 2025

Apr 01, 2025

Talphera Inc (TLPH) Q4 2024 Earnings Call Highlights: Strategic Moves and Financial Insights - Yahoo Finance

Apr 01, 2025

Mar 31, 2025

Talphera Reports 2024 Financial Results and Study Update - TipRanks

Mar 31, 2025

Mar 31, 2025

Talphera outlines 2025 timeline for NEPHRO CRRT study completion and FDA approval of Niyad - MSN

Mar 31, 2025

Mar 31, 2025

Earnings call transcript: Talphera Inc Q4 2024 shows strategic focus - Investing.com India

Mar 31, 2025

Mar 31, 2025

FDA approves Talphera’s reduced NEPHRO CRRT study size By Investing.com - Investing.com South Africa

Mar 31, 2025

Mar 31, 2025

Earnings call transcript: Talphera Inc Q4 2024 shows strategic focus By Investing.com - Investing.com UK

Mar 31, 2025

Mar 31, 2025

TLPH stock touches 52-week low at $0.5 amid market challenges By Investing.com - Investing.com South Africa

Mar 31, 2025

Mar 31, 2025

TALPHERA, INC. SEC 10-K Report - TradingView

Mar 31, 2025